Online citations, reference lists, and bibliographies.
← Back to Search

Detection Of Intracranial Abnormalities In Patients With Chronic Fatigue Syndrome: Comparison Of MR Imaging And SPECT.

R. Schwartz, B. Garada, A. Komaroff, H. Tice, M. Gleit, F. Jolesz, B. Holman
Published 1994 · Medicine

Save to my Library
Download PDF
Analyze on Scholarcy Visualize in Litmaps
Share
Reduce the time it takes to create your bibliography by a factor of 10 by using the world’s favourite reference manager
Time to take this seriously.
Get Citationsy
OBJECTIVE Chronic fatigue syndrome is a recently characterized condition of unknown origin that is manifested by fatigue, flulike complaints, and neurologic signs and symptoms, including persistent headache, impaired cognitive abilities, mood disorders, and sensorimotor disturbances. This syndrome can be difficult to diagnose clinically or by standard neuroradiologic tests. We performed MR imaging and single-photon emission computed tomography (SPECT) in patients with chronic fatigue syndrome to compare the usefulness of functional and anatomic imaging in the detection of intracranial abnormalities. SUBJECTS AND METHODS Sixteen patients who fulfilled the Centers for Disease Control, British, and/or Australian criteria for chronic fatigue syndrome had MR and SPECT examinations within a 10-week period. Axial MR and SPECT scans were analyzed as to the number and location of focal abnormalities by using analysis of variance with the Student-Newman-Keuls option. MR imaging findings in patients with chronic fatigue syndrome were compared with those in 15 age-matched control subjects, and SPECT findings in the patients with chronic fatigue syndrome were compared with those in 14 age-matched control subjects by using Fisher's exact test. The findings on MR and SPECT scans in the same patients were compared by using the Wilcoxon matched-pairs signed-ranks test. RESULTS MR abnormalities consisted of foci of T2-bright signal in the periventricular and subcortical white matter and in the centrum semiovale; there were 2.06 foci per patient, vs 0.80 foci per control subject. MR abnormalities were present in eight (50%) of 16 patients, compared with three (20%) of 15 age-matched control subjects. Neither of these differences reached significance, although the power of the study to detect differences between groups was small. Patients with chronic fatigue syndrome had significantly more defects throughout the cerebral cortex on SPECT scans than did normal subjects (7.31 vs 0.43 defects per subject, p < .001). SPECT abnormalities were present in 13 (81%) of 16 patients, vs three (21%) of 14 control subjects (p < .01). SPECT scans showed significantly more abnormalities than did MR scans in patients with chronic fatigue syndrome (p < .025). In the few patients who had repeat SPECT and MR studies, the number of SPECT abnormalities appeared to correlate with clinical status, whereas MR changes were irreversible. CONCLUSION SPECT abnormalities occur more frequently and in greater numbers than MR abnormalities do in patients with chronic fatigue syndrome. SPECT may prove to be useful in following the clinical progress of patients with this syndrome.
This paper references
10.1080/00401706.1968.10490583
Simultaneous Statistical Inference
Rupert G. Miller (1966)
10.2214/AJR.146.3.443
Periventricular hyperintensity as seen by magnetic resonance: prevalence and significance.
R. Zimmerman (1986)
10.1148/RADIOLOGY.166.3.3277247
Imaging of the aging brain. Part I. Normal findings.
B. Drayer (1988)
10.1002/ART.1780310202
Identification of brain lesions in neuropsychiatric systemic lupus erythematosus by magnetic resonance scanning.
W. McCune (1988)
10.7326/0003-4819-108-3-387
Chronic fatigue syndrome: a working case definition.
G. Holmes (1988)
10.5694/j.1326-5377.1990.tb126191.x
Prevalence of chronic fatigue syndrome in an Australian population
Andrew R Lloyd (1990)
Brain perfusion SPECT using an annular single crystal camera: initial clinical experience.
B. Holman (1990)
10.1177/014107689108400224
A Report–Chronic Fatigue Syndrome: Guidelines for Research
M. Sharpe (1991)
A comparison of brain perfusion SPECT in cocaine abuse and AIDS dementia complex.
B. Holman (1992)
10.1080/21548331.1992.11705493
Chronic fatigue syndrome.
W. Cho (1992)
10.7326/0003-4819-116-2-103
A chronic illness characterized by fatigue, neurologic and immunologic disorders, and active human herpesvirus type 6 infection.
D. Buchwald (1992)
Sequential cranial MR findings of asymptomatic and neurologically symptomatic HIV+ subjects.
M. Post (1992)
10.1097/00006231-199210000-00011
Assessment of regional cerebral perfusion by 99Tcm-HMPAO SPECT in chronic fatigue syndrome.
M. Ichise (1992)
10.1002/ART.1780360910
Single-photon-emission computed tomography analysis of cerebral blood flow in the evaluation of central nervous system involvement in patients with systemic lupus erythematosus.
A. Rubbert (1993)
10.1016/0022-510X(95)00108-E
Gait abnormalities in chronic fatigue syndrome
W. Boda (1995)



This paper is referenced by
10.3233/WOR-203178
Documenting disability in myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS).
R. Podell (2020)
10.1016/j.nicl.2020.102366
Mapping of pathological change in chronic fatigue syndrome using the ratio of T1- and T2-weighted MRI scans
K. Thapaliya (2020)
10.1186/s12967-020-02506-6
Neuroimaging characteristics of myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS): a systematic review
Zack Y. Shan (2020)
10.1007/978-3-030-57231-0_32
PET/SPECT/MRI/fMRI Studies in the Myalgic Encephalomyelitis/Chronic Fatigue Syndrome
Yasuyoshi Watanabe (2020)
10.1136/bmjopen-2019-031672
Using structural and functional MRI as a neuroimaging technique to investigate chronic fatigue syndrome/myalgic encephalopathy: a systematic review
Basim Almutairi (2020)
Evaluación de la reproducibilidad y precisión para diferentes técnicas de cuantificación en Medicina Nuclear
F. Duarte (2019)
10.1007/s11011-019-0388-6
Myalgic encephalomyelitis or chronic fatigue syndrome: how could the illness develop?
G. Morris (2019)
Small-World Network Analysis of Cortical Connectivity in Chronic Fatigue Syndrome using EEG
M. A. Zinn (2019)
10.1016/j.biopsycho.2018.05.016
Cortical hypoactivation during resting EEG suggests central nervous system pathology in patients with chronic fatigue syndrome
M. A. Zinn (2018)
10.1371/journal.pone.0200068
Intracranial compliance is associated with symptoms of orthostatic intolerance in chronic fatigue syndrome
A. Finkelmeyer (2018)
10.1371/journal.pone.0201066
Identification of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome-associated DNA methylation patterns
Malav S Trivedi (2018)
The neural correlates of effort-related and effort-unrelated fatigue in patients with multiple sclerosis
Stefan Spiteri (2018)
10.2169/internalmedicine.56.8001
Increase in the Regional Cerebral Blood Flow following Waon Therapy in Patients with Chronic Fatigue Syndrome: A Pilot Study
T. Munemoto (2017)
10.1007/s12035-017-0598-z
A Comparison of Neuroimaging Abnormalities in Multiple Sclerosis, Major Depression and Chronic Fatigue Syndrome (Myalgic Encephalomyelitis): is There a Common Cause?
G. Morris (2017)
10.11648/J.IJCEMS.20170304.11
Brain Perfusion Scintigraphy in Evaluation of Pathogenesis of Fatigue in Patients with Primary Biliary Cholangitis (PBC) – A Pilot Study
J. Raszeja-Wyszomirska (2017)
Metals in Multiple Sclerosis: Improvement or Progression
Fathi (2017)
Metabolomics reveals the relationship between the host and the gut in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome
C. Armstrong (2017)
10.1002/9781118993811.CH8
Stress and Chronic Fatigue Syndrome
B. Grinde (2017)
Fatigue post-accident vasculaire cérébral : facteurs associés et impact des troubles cognitifs et émotionnels
A. Ponchel (2016)
10.1080/17843286.2016.1196862
Chronic fatigue syndrome – an update
S. Rimbaut (2016)
Progressive Myalgic Encephalomyelitis (ME) or A New Disease? A Case Report
Howes (2016)
10.15540/NR.3.1.28
Functional Neural Network Connectivity in Myalgic Encephalomyelitis
M. L. Zinn (2016)
– Disability and Rehabilitation Progressive Myalgic Encephalomyelitis ( ME ) or A New Disease ? A Case Report
Howes (2016)
10.2174/1573397112666151231111104
Neuroimaging of Central Sensitivity Syndromes: Key Insights from the Scientific Literature.
B. Walitt (2016)
10.1007/978-3-319-09102-0_16
Differential Diagnosis of Vasovagal Syncope: Myalgic Encephalomyelitis/Chronic Fatigue Syndrome
P. Sarzi-Puttini (2015)
A prospective, proof-of-concept investigation of KPAX002 in chronic fatigue syndrome.
J. Kaiser (2015)
10.2174/1570159X13666150928105725
Myalgic Encephalomyelitis: Symptoms and Biomarkers
L. Jason (2015)
10.17554/j.issn.2313-5611.2015.01.13
The 4I Hypothesis: A Neuro-Immunological Explanation for Characteristic Symptoms of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome
Frank N M Twisk (2015)
Original Article A prospective, proof-of-concept investigation of KPAX002 in chronic fatigue syndrome
Jon D. Kaiser (2015)
10.3937/KAMPOMED.65.87
Successful Treatment of Post-influenza Chronic Fatigue Syndrome with Kampo Medicine : a Case Report
Junji Moriya (2014)
10.1007/978-3-642-40384-2_33
PET and SPECT studies in the chronic fatigue syndrome/myalgic encephalomyelitis
A. Glaudemans (2014)
10.1016/B978-0-12-801401-1.00005-0
Metabolism in chronic fatigue syndrome.
C. W. Armstrong (2014)
See more
Semantic Scholar Logo Some data provided by SemanticScholar